35 results on '"Hisashi Matsubara"'
Search Results
2. Effects of angle of incidence of stimulus light on photopic electroretinograms of zebrafish larvae
- Author
-
Hisashi Matsubara, Shinichiro Chujo, Yoko Mase, Yukiko Muramoto, Kumiko Kato, and Mineo Kondo
- Subjects
Zebrafish ,Electroretinography ,ERG ,Light stimulation ,Fiber optical cable ,Full-field stimulation ,Medicine ,Science - Abstract
Abstract In electroretinographic (ERG) recordings of zebrafish, the light stimulus is usually delivered by a fiber optic cable. The purpose of this study was to determine whether the angle of incidence of the stimulus light from the fiber optic cable will affect the amplitudes and implicit times of the ERGs of zebrafish larvae. The larvae were positioned on their side with the right eye pointed upward. The light stimuli were delivered by a fiber optic cable from three directions of the larvae: frontal 0° (F0°), dorsal 30°(D30°), and ventral 30°(V30°). Photopic ERGs were recorded from 16 larvae at age 5–6 days post-fertilization. Our results showed that the mean amplitude of the b-wave elicited at D30° and V30° stimulation was significantly smaller than that elicited at F0° stimulation (P = 0.014 and P = 0.019, respectively). In addition, the mean amplitude of the d-wave elicited at D30° and V30° stimulation was significantly smaller than that elicited at F0° stimulation (P
- Published
- 2024
- Full Text
- View/download PDF
3. Predicting postoperative visual acuity in epiretinal membrane patients and visualization of the contribution of explanatory variables in a machine learning model.
- Author
-
Akiko Irie-Ota, Yoshitsugu Matsui, Koki Imai, Yoko Mase, Keiichiro Konno, Taku Sasaki, Shinichiro Chujo, Hisashi Matsubara, Hiroharu Kawanaka, and Mineo Kondo
- Subjects
Medicine ,Science - Abstract
BackgroundThe purpose of this study was to develop a model that can predict the postoperative visual acuity in eyes that had undergone vitrectomy for an epiretinal membrane (ERM). The Light Gradient Boosting Machine (LightGBM) was used to evaluate the accuracy of the prediction and the contribution of the explanatory variables. Two models were designed to predict the postoperative visual acuity in 67 ERM patients. Model 1 used the age, sex, affected eye, axial length, preoperative visual acuity, Govetto's classification stage, and OCT-derived vector information as features to predict the visual acuity at 1, 3, and 6 months postoperatively. Model 2 incorporated the early postoperative visual acuity as an additional variable to predict the visual acuity at 3, and 6 months postoperatively. LightGBM with 100 iterations of 5-fold cross-validation was used to tune the hyperparameters and train the model. This involved addressing multicollinearity and selecting the explanatory variables. The generalized performance of these models was evaluated using the root mean squared error (RMSE) in a 5-fold cross-validation, and the contributions of the explanatory variables were visualized using the average Shapley Additive exPlanations (SHAP) values.ResultsThe RMSEs for the predicted visual acuity of Model 1 were 0.14 ± 0.02 logMAR units at 1 month, 0.12 ± 0.03 logMAR units at 3 months, and 0.13 ± 0.04 logMAR units at 6 months. High SHAP values were observed for the preoperative visual acuity and the ectopic inner foveal layer (EIFL) area with significant and positive correlations across all models. Model 2 that incorporated the postoperative visual acuity was used to predict the visual acuity at 3 and 6 months, and it had superior accuracy with RMSEs of 0.10 ± 0.02 logMAR units at 3 months and 0.10 ± 0.04 logMAR units at 6 months. High SHAP values were observed for the postoperative visual acuity in Model 2.ConclusionPredicting the postoperative visual acuity in ERM patients is possible using the preoperative clinical data and OCT images with LightGBM. The contribution of the explanatory variables can be visualized using the SHAP values, and the accuracy of the prediction models improved when the postoperative visual acuity is included as an explanatory variable. Our data-driven machine learning models reveal that preoperative visual acuity and the size of the EIFL significantly influence postoperative visual acuity. Early intervention may be crucial for achieving favorable visual outcomes in eyes with an ERM.
- Published
- 2024
- Full Text
- View/download PDF
4. Case of Repeated Full-Thickness Macular Hole Formations and Spontaneous Closure following Intravitreal Bevacizumab Treatment for Central Retinal Vein Occlusion
- Author
-
Rika Furukawa, Hisashi Matsubara, Eriko Uchiyama, Masahiko Sugimoto, and Mineo Kondo
- Subjects
central retinal vein occlusion ,macular hole ,spontaneous closure ,intravitreal injection ,Ophthalmology ,RE1-994 - Abstract
The development of a full-thickness macular hole (FTMH) is a rare complication of intravitreal injections, and only a small subset of eyes with an FTMH has a spontaneous closure. We report a case of repeated FTMH formations and a spontaneous closure following an intravitreal injection of bevacizumab (IVB) for a central retinal vein occlusion (CRVO). A 39-year-old male patient presented with reduced vision in his right eye and was diagnosed with a CRVO. Two months later, neovascular glaucoma and macular edema (ME) developed and IVB was performed. After 2 weeks, optical coherence tomography revealed an improvement of the ME and the formation of an FTMH with a hyperreflective material in the FTMH. Two months later, there was a recurrence of the ME and a closure of the FTMH, but the hyperreflective material was still present in the retina. Then, another IVB and panretinal photocoagulation were performed. One month later, the ME had improved and the FTMH was closed, but the hyperreflective material was still present in the retina. After another 2 months, the ME recurred and a third IVB was performed. The ME improved without a recurrence of an FTMH. After that, there were no recurrences of the ME, but the FTMH recurred with the progression of a posterior vitreous detachment and development of an epiretinal membrane 1 year after the third IVB. We suggest that an FTMH be included as a complication of intravitreal injections, and it may close spontaneously during the course of the primary disease.
- Published
- 2022
- Full Text
- View/download PDF
5. Transient Increase of Flicker Electroretinography Amplitudes after Cataract Surgery
- Author
-
Kumiko Kato, MD, PhD, Ryunosuke Nagashima, Hisashi Matsubara, MD, PhD, Kengo Ikesugi, MD, PhD, Hideyuki Tsukitome, MD, PhD, Yoshitsugu Matsui, MD, PhD, Takayasu Nunome, MD, Masahiko Sugimoto, MD, PhD, Daphne L. McCulloch, OD, PhD, and Mineo Kondo, MD, PhD
- Subjects
Aqueous flare value ,Cataract surgery ,Central macular thickness ,Electroretinography ,Inflammation ,Ophthalmology ,RE1-994 - Abstract
Purpose: To determine the characteristics and cause of the increase in the amplitude of flicker electroretinography (ERG) after cataract surgery. Design: Prospective, observational clinical study. Participants: Thirty patients who underwent cataract surgery. Methods: Flicker ERGs were recorded with the RETeval system without mydriasis. The central macular thickness (CMT) was measured by OCT and the aqueous flare value (AFV) by laser flare-cell photometry. These examinations were performed before surgery and 1 day, 1 week, 1 month, 2 months, and 3 months after surgery. Linear regression analysis through the origin was used to compare the correlations between the relative changes in flicker ERG amplitudes and the changes in the CMT and AFV at different times after the surgery. Main Outcome Measures: The amplitude of flicker ERGs, CMT, and AFV. Results: The mean amplitude of flicker ERGs increased significantly by 31% at 1 week after surgery (P
- Published
- 2023
- Full Text
- View/download PDF
6. Intraocular Inflammation Secondary to Intravitreal Brolucizumab Injection for Neovascular Age-Related Macular Degeneration in a Patient with Cognitive Impairment
- Author
-
Natsuki Ueji, Yoko Mase, Akiko Kubo, Hisashi Matsubara, Shinichiro Chujo, Yoshitsugu Matsui, and Mineo Kondo
- Subjects
age-related macular degeneration ,AMD ,intraocular inflammation ,IOI ,brolucizumab ,dementia ,Medicine (General) ,R5-920 - Abstract
Background and Objectives: Brolucizumab (IVBr) is a recently introduced anti-vascular endothelial growth factor (anti-VEGF) which has been found to be very effective in treating neovascular age-related macular degeneration (nAMD). We reported our findings in a case of nAMD that developed intraocular inflammation (IOI) after IVBr injections. Materials and Methods: A 79-year-old man was referred to our hospital complaining of reduced vision in both eyes of one-month’s duration. His decimal best-corrected visual acuity (BCVA) was 0.9 in the right eye and 1.0 in the left eye. He was diagnosed with nAMD in the left eye and was treated with intravitreal aflibercept (IVA). Despite the three-monthly IVA injections, the serous retinal pigment epithelial detachment (PED) and subretinal fluid (SRF) remained, and the VA gradually decreased to 0.1. Because of the patient being refractory to aflibercept treatment, we switched to 3-monthly IVBr injections. The BCVA gradually improved to 0.3 and optical coherence tomography (OCT) showed an absence of the serous PED and SRF. Three weeks after his third IVBr, he returned to our hospital with a complaint of reduced vision in his left eye that he first noted two weeks earlier. Our examination of the left eye showed signs of IOI mainly in the anterior chamber. The inflammation improved with topical steroids but the treatment of the IOI was delayed for two weeks. The patient was instructed that it was important to begin the treatment as soon as the symptoms of IOI developed. We then performed the Mini-Mental State Examination (MMSE), and his score indicated that he had cognitive impairment. Conclusions: We concluded that before beginning IVBr treatment in nAMD patients, a careful assessment must be made of the cognitive status of the patient.
- Published
- 2023
- Full Text
- View/download PDF
7. Cerebral trauma-induced dyschromatopsia in the left hemifield: case presentation
- Author
-
Yoko Mase, Yoshitsugu Matsui, Eriko Uchiyama, Hisashi Matsubara, Masahiko Sugimoto, Akiko Kubo, and Mineo Kondo
- Subjects
Acquired cerebral color anomaly ,Cerebral dyschromatopsia ,Hemilateral dyschromatopsia ,SWAP ,GCC thinning ,Retrograde transsynaptic degeneration ,Ophthalmology ,RE1-994 - Abstract
Abstract Background Acquired color anomalies caused by cerebral trauma are classified as either achromatopsias or dyschromatopsias (Zeki, Brain 113:1721–1777, 1990). The three main brain regions stimulated by color are V1, the lingual gyrus, which was designated as human V4 (hV4), and the fusiform gyrus, designated as V4α. (Zeki, Brain 113:1721–1777, 1990). An acquired cerebral color anomaly is often accompanied by visual field loss (hemi- and quadrantanopia), facial agnosia, prosopagnosia, visual agnosia, and anosognosia depending on the underlying pathology (Bartels and Zeki, Eur J Neurosci 12:172–193, 2000), (Meadows, Brain 97:615–632, 1974), (Pearman et al., Ann Neurol 5:253–261, 1979). The purpose of this study was to determine the characteristics of a patient who developed dyschromatopsia following a traumatic injury to her brain. Case presentation The patient was a 24-year-old woman who had a contusion to her right anterior temporal lobe. After the injury, she noticed color distortion and that blue objects appeared green in the left half of the visual field. Although conventional color vision tests did not detect any color vision abnormalities, short wavelength automated perimetry (SWAP) showed a decrease in sensitivity consistent with a left hemi-dyschromatopsia. Magnetic resonance imaging (MRI) detected abnormalities in the right fusiform gyrus, a part of the anterior temporal lobe. At follow-up 14 months later, subjective symptoms had disappeared, but the SWAP abnormalities persisted and a thinning of the sectorial ganglion cell complex (GCC) was detected. Conclusion The results indicate that although the subjective symptoms resolved early, a reduced sensitivity of SWAP remained and the optical coherence tomography (OCT) showed GCC thinning. We conclude that local abnormalities in the anterior section of fusiform gyrus can cause mild cerebral dyschromatopsia without other symptoms. These findings indicate that it is important to listen to the symptoms of the patient and perform appropriate tests including the SWAP and OCT at the early stage to objectively prove the presence of acquired cerebral color anomaly.
- Published
- 2021
- Full Text
- View/download PDF
8. Efficacy of Psychiatric Treatment to Treat a Specific Phobia of Intravitreal Injections in a Patient with Neovascular Age-Related Macular Degeneration
- Author
-
Atsuta Ozaki, Hisashi Matsubara, Masahiko Sugimoto, Manami Kuze, Mineo Kondo, and Takashi Shiroyama
- Subjects
specific phobia ,intravitreal injection ,psychiatric treatment ,retinal angiomatous proliferation ,cognitive-behavioral therapy ,Ophthalmology ,RE1-994 - Abstract
Intravitreal injection of anti-vascular endothelial growth factor (anti-VEGF) is essential for the treatment of macular diseases such as wet age-related macular degeneration and macular edema. Although continued treatment is needed to maintain good vision, some patients cannot continue such injections for various reasons, including specific phobias. Here, we report a case of a patient with a specific phobia of intravitreal injections who could resume treatment after undergoing combined drug and cognitive-behavioral therapy (CBT). A 74-year-old Japanese man diagnosed with retinal angiomatous proliferation by fluorescein angiography and indocyanine green angiography was treated with intravitreal anti-VEGF injection. However, at 8 months after the first treatment, he became difficult to treat because of a phobia of injections. He was treated with photodynamic therapy, but his macular edema did not improve. After a psychiatric consultation, he was diagnosed with a specific phobia of intravitreal injections. Combined drug and CBT enabled him to resume receiving intravitreal injections. This case demonstrates that a specific phobia of intravitreal injections may benefit from combined drug and CBT. In this regard, some patients with high anxiety and fear of intravitreal injections should be referred to a psychiatrist at an early stage.
- Published
- 2021
- Full Text
- View/download PDF
9. Effectiveness of Ripasudil, a Rho-Associated Coiled/Coil-Containing Protein Kinase Inhibitor, in Improving Retinoschisis and Cystic-Like Foveal Cavities in Eyes with X-Linked Retinoschisis
- Author
-
Hitomi Suimon, Masahiko Sugimoto, Hisashi Matsubara, and Mineo Kondo
- Subjects
cystic-like foveal cavities ,retinoschisis ,rho-associated coiled/coil-containing protein kinase inhibitor ,ripasudil hydrochloride hydrate ,x-linked retinoschisis ,Ophthalmology ,RE1-994 - Abstract
This is the first reported case of a successful resolution of cystic-like foveal cavities in eyes with X-linked juvenile retinoschisis (XLRS) treated with topical ripasudil hydrochloride hydrate, a Rho-associated coiled/coil-containing protein kinase (ROCK) inhibitor. A chart review was performed on 1 patient to collect all relevant clinical information and the optical coherence tomographic (OCT) images. A healthy 18-year-old young man presented with bilateral visual disturbances. The patient was diagnosed with XLRS from the spoke-wheel pattern around the macula, negative electroretinograms, and retinoschisis with cystic-like foveal cavities in the OCT images. Significant reductions of the retinoschisis and cystic-like cavities were observed after treatment with topical ripasudil. This is the first case of XLRS that had a resolution of cystic-like foveal cavities after topical ripasudil, a ROCK inhibitor. Since many XLRS patients have a worsening of their visual acuities due to the progressive nature of retinoschisis and cystic-like foveal cavities, topical ripasudil offers a potential treatment option.
- Published
- 2020
- Full Text
- View/download PDF
10. Visual prognosis of submacular hemorrhage secondary to age-related macular degeneration: A retrospective multicenter survey.
- Author
-
Naomi Inoue, Aki Kato, Takashi Araki, Takeshi Kimura, Takamasa Kinoshita, Fumiki Okamoto, Tomoya Murakami, Yoshinori Mitamura, Taiji Sakamoto, Akiko Miki, Yoshihiro Takamura, Hisashi Matsubara, Hiroki Tsujinaka, Fumi Gomi, and Tsutomu Yasukawa
- Subjects
Medicine ,Science - Abstract
PurposeTo investigate the clinical features, treatment options, and visual outcomes of submacular hemorrhage (SMH) secondary to neovascular age-related macular degeneration (nAMD).DesignA retrospective, observational case series.MethodsSetting: Multicenter institutional setting. Patient Population: A total of 127 patients (127 eyes; 88 men, 39 women; (mean age, 74.2 years)) diagnosed with AMD-associated SMHs exceeding 2 disc diameters involving the fovea. Observation: The AMD types, previous treatments, treatment options, anatomic findings, and best-corrected visual acuity (BCVA) were assessed. Main Outcome Measures: Clinical features, treatment options, and visual outcomes of SMHs secondary to nAMD.ResultsThirty-two eyes had typical AMD, 94 eyes polypoidal choroidal vasculopathy (PCV), and one eye retinal angiomatous proliferation. Eighty-five eyes were treatment-naïve; 42 eyes were treated previously: anti-vascular endothelial growth factor (VEGF) therapy (n = 26), photodynamic therapy (n = 3), and combined therapy (n = 13). Treatment of SMHs included vitrectomy (36 eyes), pneumatic displacement (49 eyes), and anti-VEGF monotherapy (42 eyes). The final BCVA improved significantly in treatment-naïve cases from 0.86 to 0.62 logarithm of the minimal angle of resolution (logMAR) unit (Snellen equivalent from 20/145 to 20/83) and from 0.80 to 0.56 (Snellen equivalent from 20/126 to 20/73) in PCV cases. Meanwhile, the BCVA logMAR values improved from 1.15 to 0.75 (Snellen equivalent from 20/283 to 20/112) and from 0.87 to 0.63 (Snellen equivalent from 20/148 to 20/85) in eyes that underwent vitrectomy or pneumatic displacement, respectively. In eyes with BCVAs between 20/133 to 20/40 at SMH onset, the final VA in the pneumatic displacement group was better than in the anti-VEGF monotherapy group. One eye had a retinal detachment and 1 eye had a macular hole in the vitrectomy group, and 5 eyes had a vitreous hemorrhage in the pneumatic displacement group.ConclusionsThe recommended treatment for SMHs secondary to nAMD exceeding 2 disc area and with BCVA below 20/40 is vitrectomy or pneumatic displacement for visual improvement.
- Published
- 2022
- Full Text
- View/download PDF
11. Differences in clinical characteristics and treatment outcomes of submacular hemorrhage caused by age-related macular degeneration and retinal macroaneurysms: A multicenter survey from the Japan Clinical Retina Study (J-CREST) group.
- Author
-
Takeshi Kimura, Takashi Araki, Tsutomu Yasukawa, Aki Kato, Soichiro Kuwayama, Takamasa Kinoshita, Fumiki Okamoto, Tomoya Murakami, Yoshinori Mitamura, Taiji Sakamoto, Hiroto Terasaki, Sentaro Kusuhara, Akiko Miki, Yoshihiro Takamura, Mineo Kondo, Hisashi Matsubara, Tetsuo Ueda, Hiroki Tsujinaka, and Fumi Gomi
- Subjects
Medicine ,Science - Abstract
PurposeTo evaluate the clinical characteristics, treatment trends, and visual prognosis of submacular hemorrhage (SMH) secondary to neovascular age-related macular degeneration (nAMD) and retinal arterial macroaneurysm (RAM).MethodsThis retrospective study enrolled 187 Japanese patients with SMH at 10 institutions from 2015 to 2018. Medical records including SMH etiology, best-corrected visual acuity (BCVA), fundus photographs, optical coherence tomography images, and selected treatments were analyzed.ResultsMajor causes of SMH were typical nAMD (tnAMD) (18%), polypoidal choroidal vasculopathy (PCV) (50%) and RAM (29%). Age, male/female ratio, baseline BCVA, central retinal thickness, and involved retinal layers were significantly different between etiologies (all PConclusionsThe characteristics of, and treatment strategy for, SMH were different between the underlying diseases. Anti-vascular endothelial growth factor treatment with or without expansile gas was mainly chosen for SMH in tnAMD and PCV, whereas vitrectomy with gas was the most common treatment for RAM, and the higher rate for vitrectomy might result in the greater BCVA improvement in the RAM group than in the other groups. Final BCVA was better in PCV, RAM, and tnAMD, in that order, because patients with PCV were younger and had better baseline BCVA.
- Published
- 2022
- Full Text
- View/download PDF
12. A Case of Focal Choroidal Excavation Development Associated with Multiple Evanescent White Dot Syndrome
- Author
-
Hisashi Matsubara, Eriko Uchiyama, Katsuya Suzuki, Yoshito Matsuda, and Mineo Kondo
- Subjects
Choroidal excavation ,Choroidal thickness ,Multiple evanescent white dot syndrome ,Optical coherence tomography ,Ophthalmology ,RE1-994 - Abstract
Focal choroidal excavation (FCE) is described as an excavated lesion of the choroid that can be detected by optical coherence tomography (OCT). While the exact pathogenesis of FCE remains unclear, it has been proposed in some cases that there is an association with the inflammation in the outer retina. We present a case of FCE development that was detected by spectral domain OCT (SD-OCT) and found to be associated with multiple evanescent white dot syndrome (MEWDS). A 40-year-old Japanese woman was diagnosed with MEWDS based on multiple white dots observed from the posterior pole to the midperiphery, along with yellow granularity in the fovea. SD-OCT revealed separation between the retinal pigment epithelium (RPE) and Bruch’s membrane (BM) and discontinuations of the ellipsoid zone, RPE, and BM. At 4 weeks after onset, several of the white dots disappeared, the yellow granularity in the fovea became small, and we detected nonconforming choroidal excavation under the central fovea. The choroidal excavation gradually deepened and changed to a conforming pattern. These findings suggest that the degree of the impairment caused by inflammation and the plasticity of the BM and RPE complex may be associated with different types of acquired FCE.
- Published
- 2018
- Full Text
- View/download PDF
13. A Case of Sustained Intraocular Pressure Elevation after Multiple Intravitreal Injection of Ranibizumab and Aflibercept for Neovascular Age-Related Macular Degeneration
- Author
-
Hisashi Matsubara, Ryohei Miyata, Maki Kobayashi, Hideyuki Tsukitome, Kengo Ikesugi, and Mineo Kondo
- Subjects
Age-related macular degeneration ,Anti-vascular endothelial growth factor ,Ranibizumab ,Aflibercept ,Multiple intravitreal injections ,Medication switching ,Intraocular pressure ,Ocular hypertension ,Ophthalmology ,RE1-994 - Abstract
Intravitreal injections of anti-vascular endothelial growth factor (VEGF) agents are widely used to treat neovascular age-related macular degeneration (nAMD). Although these treatments are effective, multiple injections have recently been recommended to ensure that there is a good long-term prognosis. However, sustained intraocular pressure (IOP) elevations have been reported to develop after multiple injections of anti-VEGF agents. We present our findings of a case of uncontrolled and persistent IOP elevation after switching from intravitreal ranibizumab injections to intravitreal aflibercept injections. A 74-year-old Japanese man without a history of glaucoma underwent 22 ranibizumab injections for nAMD and suddenly developed an elevated IOP after the 22nd injection. Although the subsequent medical treatment led to normalization of his IOP, the subretinal fluid under the central fovea remained even after the 25th injection of ranibizumab. Thus, ranibizumab treatment was switched to bimonthly intravitreal aflibercept injections in conjunction with glaucoma medications. His IOP recovered to within the normal range; however, after the 11th aflibercept injection, there was a sudden elevation of his IOP in spite of the continued glaucoma medications. Due to this sustained IOP elevation, his aflibercept injections were suspended for 16 weeks. Because his IOP could not be normalized by a full glaucoma medication regimen, the patient underwent trabeculotomy, which resulted in a lowering of the IOP to normal levels. We conclude that patients who receive serial intravitreal injections of anti-VEGF agents need to be closely monitored because severe and sustained ocular hypertension can develop.
- Published
- 2016
- Full Text
- View/download PDF
14. Method of Quantifying Size of Retinal Hemorrhages in Eyes with Branch Retinal Vein Occlusion Using 14-Square Grid: Interrater and Intrarater Reliability
- Author
-
Yuko Takashima, Masahiko Sugimoto, Kumiko Kato, Maki Kozawa, Kengo Ikesugi, Hisashi Matsubara, and Mineo Kondo
- Subjects
Ophthalmology ,RE1-994 - Abstract
Purpose. To describe a method of quantifying the size of the retinal hemorrhages in branch retinal vein occlusion (BRVO) and to determine the interrater and intrarater reliabilities of these measurements. Methods. Thirty-five fundus photographs from 35 consecutive eyes with BRVO were studied. The fundus images were analyzed with Power-Point® software, and a grid of 14 squares was laid over the fundus image. Raters were asked to judge the percentage of each of the 14 squares that was covered by the hemorrhages, and the average of the 14 squares was taken to be the relative size of the retinal hemorrhage. Results. Interrater reliability between three raters was higher when a grid with 14 squares was used (intraclass correlation coefficient (ICC), 0.96) than that when a box with no grid was used (ICC, 0.78). Intrarater reliability, which was calculated by the retinal hemorrhage area measured on two different days, was also higher (ICC, 0.97) than that with no grid (ICC, 0.86). Interrater reliability for five fundus pictures with poor image quality was also good when a grid with 14 squares was used (ICC, 0.88). Conclusions. Although our method is subjective, excellent interrater and intrarater reliabilities indicate that this method can be adapted for clinical use.
- Published
- 2016
- Full Text
- View/download PDF
15. Changes in outer retinal microstructures during six month period in eyes with acute zonal occult outer retinopathy-complex.
- Author
-
Yoshitsugu Matsui, Hisashi Matsubara, Shinji Ueno, Yasuki Ito, Hiroko Terasaki, and Mineo Kondo
- Subjects
Medicine ,Science - Abstract
PURPOSE: To study the changes in the outer retinal microstructures during a six month period after the onset of acute zonal occult outer retinopathy (AZOOR)-complex by spectral-domain optical coherence tomography (SD-OCT). METHODS: Seventeen eyes of 17 patients with the AZOOR-complex were studied. The integrity of the external limiting membrane (ELM), ellipsoid zone (EZ; also called the inner/outer segment junction), and interdigitation zone (IDZ; also called the cone outer segment tips) were evaluated in the SD-OCT images obtained at the initial visit and at six months. The three highly reflective bands were divided into three types; continuous, discontinuous, and absent. The integrity of the outer nuclear layer (ONL) was also assessed. RESULTS: Among the three highly reflective bands, the IDZ was most altered at the initial visit and least recovered at six months. Fifteen of 17 eyes (88%) had a recovery of at least one of the three bands at six months in the retinal area where the ONL was intact, and these areas showed an improvement of visual field. Three eyes (18%) had retinal areas where the ONL was absent at the initial visit, and there was no recovery in both the retinal structures and visual fields in these areas. CONCLUSIONS: Our results indicate that more than 85% eyes with AZOOR-complex show some recovery in the microstructures of the outer retina during a six month period if the ONL is intact. We conclude that SD-OCT is a useful method to monitor the changes of the outer retinal microstructure in eyes with the AZOOR-complex.
- Published
- 2014
- Full Text
- View/download PDF
16. Study of specific IgE and IgG4 antibodies to mite antigen in asthmatic children during immunotherapy
- Author
-
Hiroyuki Matsuoka, Yutaka Atsuta, Hisashi Matsubara, Motoi Adachi, Yukari Matsushita, Toshihide Obe, Katsuhiko Ando, and Yasuo Chinzei
- Subjects
bronchial asthma ,densitometer ,Dermatophagoides ,IgE ,lgG4 ,immunoblotting ,immunotherapy ,Immunologic diseases. Allergy ,RC581-607 - Abstract
Using immunoblotting and densitometer techniques, we followed the levels of IgE and IgG4 antibodies to Dermatophagoides farinae antigen in the sera of 12 asthmatic children during immunotherapy, repeated injections of house dust extract, for 2 years. The symptoms of asthma were reduced or disappeared by the 6th month after starting immunotherapy in 12 children. Two years later, RAST scores to house dust and D. farinae in each child were still 4 or 5. The levels of IgE antibodies to Der fII in all cases did not change drastically. IgE antibodies to higher molecular weight antigens (Der fI, fIII, fIV etc.) developed in some cases, suggesting that repeated injections of crude extract tended to induce IgE antibodies to alternative molecules in patients. The IgG4 antibody to Der fII increased in 10 cases, while that to Der fI increased in three of 12 cases, indicating that production of IgG4 antibodies to mite antigens started and expanded with repeated injections of house dust extract. The amount of induced IgG4 antibodies to Der fI and Der fII was not enough to inhibit the immunoblot reaction of IgE antibodies to these molecules.
- Published
- 1998
- Full Text
- View/download PDF
17. THREE CASES OF ACUTE RETINAL NECROSIS WITH ATYPICAL FUNDUS FINDINGS.
- Author
-
Shinichiro Chujo, Hisashi Matsubara, Atsushi Ichio, Yoshitsugu Matsui, Masahiko Sugimoto, and Mineo Kondo
- Abstract
Purpose: To determine the mechanism for the development of segmental granular lesions along the retinal vessels in eyes with acute retinal necrosis. Method: This was a retrospective analysis of the medical records of three eyes of three patients who were diagnosed with acute retinal necrosis that had atypical segmental granular lesions aligned along the retinal vessels. Results: The segmental granular lesions were present on the retinal arteries and veins throughout the retina. Optical coherence tomography showed that the granular lesions protruded into the vitreous cavity. Histopathologic examinations confirmed that the lesions were made up of lymphocytes. Conclusion: We suggest that the granular lesions were formed by a mechanism similar to that of HTLV-1-associated uveitis. We also found that the granular lesions disappeared soon after vitrectomy. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
18. Comparisons of Clinical Characteristics and Surgical Outcomes of Epiretinal Membrane Foveoschisis to Typical Epiretinal Membrane
- Author
-
Kondo, Taku Sasaki, Yoshitsugu Matsui, Kumiko Kato, Shinichiro Chujo, Satoshi Maeda, Atsuta Ozaki, Kengo Ikesugi, Masahiko Sugimoto, Hisashi Matsubara, and Mineo
- Subjects
epiretinal membrane ,epiretinal membrane foveoschisis ,sex ,vitrectomy - Abstract
Epiretinal membrane (ERM) foveoschisis is a recently proposed clinical entity. The purpose of this study was to compare the clinical characteristics and surgical outcomes of eyes with ERM foveoschisis to those of typical ERM. The medical records of all patients with ERM-related disorders examined between 2011 and 2020 were reviewed. ERM foveoschisis was defined by the clinical criteria proposed by an international panel of experts on ERMs. The background factors, clinical characteristics, and surgical outcomes of ERM foveoschisis were compared to those of typical ERM. Forty eyes with ERM foveoschisis were compared to 333 eyes with typical ERM. The percentage of women was significantly higher in the ERM foveoschisis group (92.5%) than in the typical ERM group (48.9%, p < 0.001). The central macular thickness (CMT) was significantly thinner in the ERM foveoschisis group (340 ± 110 μm) than in the typical ERM groups (476 ± 111 μm, p < 0.01). The degree of improvement in the best-corrected visual acuity (BCVA) three months after the surgery did not differ between the two groups (p = 0.59). These results suggest that the ERM foveoschisis is more likely to occur in women and that the prognosis after surgery is comparable to typical ERM.
- Published
- 2023
- Full Text
- View/download PDF
19. Suspension of Anti-VEGF Treatment Does Not Affect Expansion of RPE Atrophy in Neovascular Age-Related Macular Degeneration
- Author
-
Shinichiro Chujo, Hisashi Matsubara, Yoshitsugu Matsui, Masahiko Sugimoto, and Mineo Kondo
- Subjects
General Medicine ,age-related macular degeneration ,AMD ,anti-VEGF agent ,intravitreal injection ,treatment suspension ,RPE atrophy - Abstract
Purpose: To determine whether atrophy of the retinal pigment epithelium (RPE) in eyes with neovascular age-related macular degeneration (nAMD), which meets the criteria for the suspension of anti-vascular endothelial growth factor (anti-VEGF) treatment, is associated with anti-VEGF treatments. Methods: Twelve eyes of 12 patients with nAMD who began anti-VEGF treatment and were followed for 1 year after meeting the criteria for the suspension of anti-VEGF were studied. Six eyes of six patients were placed in the continuation group, and six eyes of six patients were placed in the suspension group. The RPE atrophic area at the time of the last anti-VEGF treatment was set as the baseline size and that at 12 months after the baseline (Month 12) was taken as the final size. A comparison of the expansion rate of RPE atrophy between the two groups was made by the square-root transformed differences. Results: The expansion rate of atrophy was 0.55 (0.43, 0.72) mm/year in the continuation group and 0.33 (0.15, 0.41) mm/year in the suspension group. This difference was not significant. (p = 0.29). Conclusions: Suspension of anti-VEGF treatments in eyes with nAMD does not alter the expansion rate of RPE atrophy.
- Published
- 2023
- Full Text
- View/download PDF
20. Impact of the COVID-19 Pandemic on Anti-Vascular Endothelial Growth Factor Therapy for Diabetic Macular Edema in Japan
- Author
-
Ryohei Komori, Yoshihiro Takamura, Yutaka Yamada, Masakazu Morioka, Hisashi Matsubara, Takao Hirano, Yoshinori Mitamura, Miho Shimizu, Sentaro Kusuhara, Tomoya Murakami, Ryotaro Nihei, Tetsuo Ueda, Hiroshi Kunikata, Tatsuya Jujo, Hiroto Terasaki, Daisuke Nagasato, Kousuke Noda, Rie Osaka, Kazuki Nagai, Shigeo Yoshida, Miho Nozaki, Hidetaka Noma, Gaku Ishigooka, Aya Takahashi, Osamu Sawada, Kazuhiro Kimura, and Masaru Inatani
- Subjects
anti-VEGF therapy ,COVID-19 ,diabetic macular edema ,General Medicine - Abstract
Anti-vascular endothelial growth factor (VEGF) therapy for diabetic macular edema (DME) improves visual acuity. However, repeated injections during routine outpatient visits are required to maintain this effect. The recent sudden global outbreak of coronavirus disease 2019 (COVID-19) had a major impact on daily life, including medical care, such as the provision of VEGF therapy. We retrospectively investigated the relationship between the number of anti-VEGF injections for DME and the number of new COVID-19-positive patients at 23 centers in Japan. We also surveyed ophthalmologists regarding the impact of the COVID-19 pandemic on anti-VEGF therapy. In the third and fourth waves of the pandemic, when the number of infected patients increased, the number of injections significantly decreased. In the first, third, and fourth waves, the number of injections increased significantly during the last month of each wave. Approximately 60.9% of ophthalmologists reported that the number of injections decreased after the pandemic. Of the facilities, 52.2% extended the clinic visit intervals; however, there was no significant difference in the actual number of injections given between before and after the pandemic. Although the number of injections temporarily decreased, Japanese ophthalmologists maintained the total annual number of anti-VEGF injections for DME during the pandemic.
- Published
- 2022
- Full Text
- View/download PDF
21. Which Explanatory Variables Contribute to the Classification of Good Visual Acuity over Time in Patients with Branch Retinal Vein Occlusion with Macular Edema Using Machine Learning?
- Author
-
Yoshitsugu Matsui, Kazuya Imamura, Shinichiro Chujo, Yoko Mase, Hisashi Matsubara, Masahiko Sugimoto, Hiroharu Kawanaka, and Mineo Kondo
- Subjects
optical coherence tomography ,branch retinal vein occlusion ,fovea ,macular ,logistic regression ,machine learning ,clinical prediction models ,General Medicine - Abstract
This study’s goal is to determine the accuracy of a linear classifier that predicts the prognosis of patients with macular edema (ME) due to a branch retinal vein occlusion during the maintenance phase of antivascular endothelial growth factor (anti-VEGF) therapy. The classifier was created using the clinical information and optical coherence tomographic (OCT) findings obtained up to the time of the first resolution of ME. In total, 66 eyes of 66 patients received an initial intravitreal injection of anti-VEGF followed by repeated injections with the pro re nata (PRN) regimen for 12 months. The patients were divided into two groups: those with and those without good vision during the PRN phase. The mean AUC of the classifier was 0.93, and the coefficients of the explanatory variables were: best-corrected visual acuity (BCVA) at baseline was 0.66, BCVA at first resolution of ME was 0.51, age was 0.21, the average brightness of the ellipsoid zone (EZ) was −0.12, the intactness of the external limiting membrane (ELM) was −0.14, the average brightness of the ELM was −0.17, the brightness value of EZ was −0.17, the area of the outer segments of the photoreceptors was −0.20, and the intactness of the EZ was −0.24. This algorithm predicted the prognosis over time for individual patients during the PRN phase.
- Published
- 2022
- Full Text
- View/download PDF
22. Efficacy of Psychiatric Treatment to Treat a Specific Phobia of Intravitreal Injections in a Patient with Neovascular Age-Related Macular Degeneration
- Author
-
Masahiko Sugimoto, Atsuta Ozaki, Hisashi Matsubara, Takashi Shiroyama, Mineo Kondo, and Manami Kuze
- Subjects
medicine.medical_specialty ,Specific phobia ,Cognitive-behavioral therapy ,genetic structures ,medicine.medical_treatment ,High anxiety ,Case Report ,01 natural sciences ,behavioral disciplines and activities ,03 medical and health sciences ,Retinal angiomatous proliferation ,0302 clinical medicine ,lcsh:Ophthalmology ,Intravitreal injection ,Ophthalmology ,Age related ,mental disorders ,medicine ,0101 mathematics ,Macular edema ,medicine.diagnostic_test ,business.industry ,Psychiatric treatment ,010102 general mathematics ,Macular degeneration ,Fluorescein angiography ,medicine.disease ,Cognitive behavioral therapy ,Psychiatric consultation ,lcsh:RE1-994 ,030221 ophthalmology & optometry ,business - Abstract
Intravitreal injection of anti-vascular endothelial growth factor (anti-VEGF) is essential for the treatment of macular diseases such as wet age-related macular degeneration and macular edema. Although continued treatment is needed to maintain good vision, some patients cannot continue such injections for various reasons, including specific phobias. Here, we report a case of a patient with a specific phobia of intravitreal injections who could resume treatment after undergoing combined drug and cognitive-behavioral therapy (CBT). A 74-year-old Japanese man diagnosed with retinal angiomatous proliferation by fluorescein angiography and indocyanine green angiography was treated with intravitreal anti-VEGF injection. However, at 8 months after the first treatment, he became difficult to treat because of a phobia of injections. He was treated with photodynamic therapy, but his macular edema did not improve. After a psychiatric consultation, he was diagnosed with a specific phobia of intravitreal injections. Combined drug and CBT enabled him to resume receiving intravitreal injections. This case demonstrates that a specific phobia of intravitreal injections may benefit from combined drug and CBT. In this regard, some patients with high anxiety and fear of intravitreal injections should be referred to a psychiatrist at an early stage.
- Published
- 2021
23. Effects of recording sequence on flicker electroretinographics recorded with natural pupils corrected for pupil area
- Author
-
Asako Sugawara, Hisashi Matsubara, Mineo Kondo, Kumiko Kato, Ryunosuke Nagashima, Kengo Ikesugi, Daphne L. McCulloch, and Masahiko Sugimoto
- Subjects
Adult ,Male ,medicine.medical_specialty ,Pupil diameter ,fundamental component ,Visual Acuity ,flicker ERG ,Audiology ,Stimulus (physiology) ,Pupil ,Retina ,03 medical and health sciences ,Young Adult ,0302 clinical medicine ,Mydriasis ,Medicine ,Humans ,Prospective Studies ,business.industry ,Flicker ,General Medicine ,Original Articles ,RETeval ,Recording system ,Middle Aged ,pupil diameter ,implicit times ,Ophthalmology ,030221 ophthalmology & optometry ,Original Article ,Female ,medicine.symptom ,business ,Erg ,030217 neurology & neurosurgery ,Photic Stimulation ,Photopic vision - Abstract
Background A new handheld electroretinographic (ERG) recording system can record ERGs without mydriasis. However, this RETeval system cannot record ERGs from both eyes simultaneously. Thus, the purpose of this study was to determine whether the sequence of the ERG recordings will alter the results. Methods We studied 30 eyes of 30 healthy subjects. The flicker ERGs were recorded with the RETeval system without mydriasis and were elicited by 8, 16 and 32 photopic Td‐s. The flicker ERGs were recorded at two sessions. Session 1, the ERGs were recorded from the right eye and then the left eye, and Session 2, ERGs were recorded from the left eye then the right eye. We compared the implicit times, amplitudes and pupil diameters of the right eye between these two sessions. Results The implicit time of the flicker ERGs was significantly shorter (p
- Published
- 2020
24. Comparison of 2-Year Outcomes between Intravitreal Ranibizumab and Intravitreal Aflibercept for Diabetic Macular Edema with 'Treat-and-Extend' Regimen—Its Usefulness and Problems
- Author
-
Hisashi Matsubara, Atsushi Ichio, Ryohei Miyata, Masahiko Sugimoto, Shinichiro Chujo, Mineo Kondo, Kumiko Kato, Taku Sasaki, and Yoshitsugu Matsui
- Subjects
medicine.medical_specialty ,Visual acuity ,genetic structures ,Diabetic macular edema ,lcsh:Medicine ,Article ,03 medical and health sciences ,0302 clinical medicine ,Ophthalmology ,medicine ,ranibizumab ,treat-and-extend regimen ,030304 developmental biology ,Aflibercept ,0303 health sciences ,business.industry ,aflibercept ,lcsh:R ,Retrospective cohort study ,General Medicine ,Diabetic retinopathy ,medicine.disease ,eye diseases ,Regimen ,030221 ophthalmology & optometry ,sense organs ,Intravitreal ranibizumab ,Ranibizumab ,medicine.symptom ,business ,diabetic macular edema ,medicine.drug - Abstract
Background: To compare the effectiveness of intravitreal ranibizumab (IVR) and intravitreal aflibercept (IVA) performed with the treat-and-extend (TAE) regimen on eyes with diabetic macular edema (DME). Patients and methods: This is a retrospective study of 125 eyes of 125 treatment-naï, ve DME patients who received anti-VEGF injections at three consecutive monthly intervals as the loading phase. The changes in the best-corrected visual acuity (BCVA), central retinal thickness (CRT), diabetic retinopathy severity scale (DRSS), and total injection numbers were compared between the two anti-VEGF agents. Results: Among 125 eyes, 26 eyes completed the treatment with the TAE regimen for 24 months (20.8%). Thirteen eyes of 13 patients (mean age, 70.9 ±, 6.0 years) received intravitreal injections of 0.5 mg ranibizumab, and 13 eyes of 13 patients (65.9 ±, 8.6 years) received 2 mg aflibercept. No significant differences were detected in the baseline demographics. At 24 months, BCVA was significantly improved in both groups, from 0.31 ±, 0.19 to 0.10 ±, 0.12 logMAR units for IVR and 0.41 ±, 0.19 to 0.16 ±, 0.28 logMAR units for IVA (p = 1.29 ×, 10&minus, 9). CRT was significantly reduced in both groups, 440.9 ±, 69.3 to 307.5 ±, 66.4 &mu, m for IVR and 473.9 ±, 71.5 to 317.8 ±, 71.2 &mu, m for IVA (p = 3.55 ×, 9). No significant differences were detected in the improvements of BCVA, CRT in both groups, and the total injection numbers for 24 months (11.0 ±, 1.2 for the IVA group and 12.0 ±, 1.0 the IVR group). DRSS was significantly improved in both groups (p = 0.0004 for IVR and p = 0.009 for IVA). Conclusion: No significant differences were detected in the improvements of BCVA or CRT and injection numbers between the IVR and IVA groups treated with the TAE regimen. These results indicate that the results of the treatment with both agents with the TAE regimen were equally effective, but only 20.8% of patients completed 24 months of continuous treatment with the TAE regimen. Synopsis: There are no significant differences regarding effectiveness between the IVR and IVA groups treated with the TAE regimen for DME eyes.
- Published
- 2020
25. A Case of Sustained Intraocular Pressure Elevation after Multiple Intravitreal Injection of Ranibizumab and Aflibercept for Neovascular Age-Related Macular Degeneration
- Author
-
Ryohei Miyata, Maki Kobayashi, Kengo Ikesugi, Mineo Kondo, Hisashi Matsubara, and Hideyuki Tsukitome
- Subjects
medicine.medical_specialty ,Intraocular pressure ,genetic structures ,medicine.medical_treatment ,Ocular hypertension ,Glaucoma ,Case Report ,03 medical and health sciences ,0302 clinical medicine ,lcsh:Ophthalmology ,Ophthalmology ,Ranibizumab ,Medicine ,Medication switching ,Anti-vascular endothelial growth factor ,Aflibercept ,Glaucoma medication ,business.industry ,Age-related macular degeneration ,Multiple intravitreal injections ,Macular degeneration ,medicine.disease ,Trabeculotomy ,eye diseases ,lcsh:RE1-994 ,030221 ophthalmology & optometry ,sense organs ,business ,030217 neurology & neurosurgery ,medicine.drug - Abstract
Intravitreal injections of anti-vascular endothelial growth factor (VEGF) agents are widely used to treat neovascular age-related macular degeneration (nAMD). Although these treatments are effective, multiple injections have recently been recommended to ensure that there is a good long-term prognosis. However, sustained intraocular pressure (IOP) elevations have been reported to develop after multiple injections of anti-VEGF agents. We present our findings of a case of uncontrolled and persistent IOP elevation after switching from intravitreal ranibizumab injections to intravitreal aflibercept injections. A 74-year-old Japanese man without a history of glaucoma underwent 22 ranibizumab injections for nAMD and suddenly developed an elevated IOP after the 22nd injection. Although the subsequent medical treatment led to normalization of his IOP, the subretinal fluid under the central fovea remained even after the 25th injection of ranibizumab. Thus, ranibizumab treatment was switched to bimonthly intravitreal aflibercept injections in conjunction with glaucoma medications. His IOP recovered to within the normal range; however, after the 11th aflibercept injection, there was a sudden elevation of his IOP in spite of the continued glaucoma medications. Due to this sustained IOP elevation, his aflibercept injections were suspended for 16 weeks. Because his IOP could not be normalized by a full glaucoma medication regimen, the patient underwent trabeculotomy, which resulted in a lowering of the IOP to normal levels. We conclude that patients who receive serial intravitreal injections of anti-VEGF agents need to be closely monitored because severe and sustained ocular hypertension can develop.
- Published
- 2016
26. Incidence of retinal detachment associated with atopic dermatitis in Japan: review of cases from 1992 to 2011
- Author
-
Motoyasu Furuta, Yoshitsugu Matsui, Hitoshi Mizutani, Hisashi Matsubara, Mineo Kondo, Keiichi Yamanaka, and Mikio Sasoh
- Subjects
medicine.medical_specialty ,ocular complication ,atopic dermatitis ,business.industry ,Incidence (epidemiology) ,Retinal detachment ,Clinical Ophthalmology ,Atopic dermatitis ,medicine.disease ,Ocular complication ,body regions ,Ophthalmology ,retinal detachment ,incidence ,Medicine ,business ,Original Research - Abstract
Mikio Sasoh,1,2 Hitoshi Mizutani,3 Hisashi Matsubara,1 Motoyasu Furuta,4 Yoshitsugu Matsui,1 Kei-ichi Yamanaka,3 Mineo Kondo11Department of Ophthalmology, Graduate School of Medicine, Mie University, Tsu, 2Local Independent Administrative Institution, Mie Prefectural General Medical Center, Yokkaichi, 3Department of Dermatology, Graduate School of Medicine, Mie University, Tsu, 4Japanese Red Cross Ise Hospital, Ise,Mie, JapanPurpose: The present study aims to investigate the number and characteristics of retinal detachment with atopic dermatitis (AD) in these 20years, and the number of the first visit AD outpatients in almost the same period.Methods: A retrospective review of 101 consecutive surgically treated retinal detachments with AD patients from 1992 to 2011 was conducted. Retinal detachments were divided into two groups: eyes operated on from 1992 to 2001 (former AD group, n=63) and eyes operated on from 2002 to 2011 (recent AD group, n=38). We also reviewed the records of the first visit AD outpatients from 1993 to 2011 except 1998.Results: The percentage of bilateral detachment was significantly higher in the former AD group (14/63) than that in the recent AD group (0/38) (P=0.0002). In addition, patients in the recent AD group were significantly older than those in the former AD group (P=0.0084). The annual cases with non-AD retinal detachment remained invariant for 20years. The ratio of the retinal detachment with AD for the total retinal detachment was significantly lower in the recent (38/847) AD group than that in the former (63/796) AD group (P=0.0038). The number of the first visit AD outpatients linearly decreased in these 19 years (153 cases in 1993 and 65cases in 2011).Conclusion: Our study indicates an apparent decrease in retinal detachment with AD in the recent 10years, and might suggest the importance of dermatitis control for prevention of retinal detachment with AD.Keywords: atopic dermatitis, incidence, ocular complication, retinal detachment
- Published
- 2015
27. Fabrication technique of obturator-type sports mouthguard for a patient who had undergone maxillectomy and its speech intelligibility assessment: A case report.
- Author
-
Kairi Hayashi, Hiroshi Churei, Shrestha, Abhishekhi, Tatsu Suzuki, Hisashi Matsubara, Takafumi Otomaru, Sumita, Yuka, Chowdhury, Ruman Uddin, Chowdhry, Nafees Uddin, and Toshiaki Ueno
- Subjects
INTELLIGIBILITY of speech ,MOUTH protectors ,MAXILLECTOMY ,RUGBY football ,PROSTHETICS ,BRAIN concussion ,ARTIFICIAL palates ,VELOPHARYNGEAL insufficiency ,VERBAL behavior testing - Abstract
Purpose: Wearing a sports mouthguard is not only recommended in collision sports, such as American football, boxing, and rugby football, but also in lowcontact sports, such as basketball, handball, and soccer. It is recommended to remove oral prosthetic devices while playing sports to avoid the risk of fracturing the device. However, players with maxillectomy must wear obturator-type prosthetic devices for speech, breathing, and deglutition even while playing sports. Therefore, there is a need for an oral appliance to prevent dental injury while playing sports without the risk of fracturing the device for players who have undergone maxillectomy. In this case, we fabricated and proposed overlay-type and obturator-type customized sports mouthguards for a patient who had undergone maxillectomy and assessments of satisfaction, speech intelligibility, nasopharyngeal closure function, and swallowing function while playing soccer. Results: The patient was only satisfied with the obturator-type mouthguard, and the results of the speech intelligibility, nasopharyngeal closure function, and swallowing tests using the obturator-type mouthguard showed no differences compared to those associated with the previously used prosthetic device. Conclusions: This case may help highlight the importance of providing obturator-type mouthguards for players who have undergone maxillectomy to prevent dental injury and physical and mental discomfort. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
28. Peripheral capillary nonperfusion and full-field electroretinographic changes in eyes with frosted branch-like appearance retinal vasculitis
- Author
-
Eriko Uchiyama, Hisashi Matsubara, Yoshitsugu Matsui, Tatsuya Yagi, Hideyuki Tsukitome, Mineo Kondo, and Yuko Wada
- Subjects
medicine.medical_specialty ,Pathology ,Visual acuity ,genetic structures ,electroretinogram ,Case Report ,Fundus (eye) ,Cerebrospinal fluid ,Ophthalmology ,medicine ,Macular edema ,frosted branch angiitis ,optical coherence tomography ,medicine.diagnostic_test ,Retinal vasculitis ,business.industry ,medicine.disease ,Fluorescein angiography ,eye diseases ,oscillatory potentials ,aseptic meningitis ,sense organs ,medicine.symptom ,Headaches ,business ,Electroretinography - Abstract
We report a patient with frosted branch-like appearance retinal vasculitis associated with peripheral capillary nonperfusion and full-field electroretinographic changes. A 62-year-old man presented with sudden bilateral decreased vision accompanied by headaches. His best-corrected visual acuity was 0.01 in both eyes. Fundus examination and fluorescein angiography showed bilateral frosted branch-like appearance retinal vasculitis, and spectral-domain optical coherence tomography showed severe macular edema in both eyes. The cerebrospinal fluid analyses showed an increased lymphocyte count and protein levels. He was treated with systemic corticosteroid therapy, and his best-corrected visual acuity improved to 0.8 OD and 1.0 OS at 6 months after onset. However, fluorescein angiography showed a lack of capillary perfusion in the periphery, and the oscillatory potentials on full-field electroretinography were severely reduced in both eyes. These findings indicated extensive retinal ischemia and inner retinal dysfunction, and that fluorescein angiography and full-field electroretinograms can be useful during follow-up of eyes with frosted branch-like appearance retinal vasculitis.
- Published
- 2013
29. Method of Quantifying Size of Retinal Hemorrhages in Eyes with Branch Retinal Vein Occlusion Using 14-Square Grid: Interrater and Intrarater Reliability
- Author
-
Masahiko Sugimoto, Kumiko Kato, Kengo Ikesugi, Hisashi Matsubara, Mineo Kondo, Yuko Takashima, and Maki Kozawa
- Subjects
Square tiling ,medicine.medical_specialty ,Article Subject ,genetic structures ,Intraclass correlation ,Image quality ,03 medical and health sciences ,chemistry.chemical_compound ,0302 clinical medicine ,lcsh:Ophthalmology ,Ophthalmology ,Medicine ,business.industry ,Retinal ,Intra-rater reliability ,medicine.disease ,eye diseases ,Surgery ,Inter-rater reliability ,medicine.anatomical_structure ,chemistry ,Fundus (uterus) ,lcsh:RE1-994 ,030221 ophthalmology & optometry ,Branch retinal vein occlusion ,business ,030217 neurology & neurosurgery ,Research Article - Abstract
Purpose. To describe a method of quantifying the size of the retinal hemorrhages in branch retinal vein occlusion (BRVO) and to determine the interrater and intrarater reliabilities of these measurements.Methods. Thirty-five fundus photographs from 35 consecutive eyes with BRVO were studied. The fundus images were analyzed with Power-Point® software, and a grid of 14 squares was laid over the fundus image. Raters were asked to judge the percentage of each of the 14 squares that was covered by the hemorrhages, and the average of the 14 squares was taken to be the relative size of the retinal hemorrhage.Results. Interrater reliability between three raters was higher when a grid with 14 squares was used (intraclass correlation coefficient (ICC), 0.96) than that when a box with no grid was used (ICC, 0.78). Intrarater reliability, which was calculated by the retinal hemorrhage area measured on two different days, was also higher (ICC, 0.97) than that with no grid (ICC, 0.86). Interrater reliability for five fundus pictures with poor image quality was also good when a grid with 14 squares was used (ICC, 0.88).Conclusions. Although our method is subjective, excellent interrater and intrarater reliabilities indicate that this method can be adapted for clinical use.
- Published
- 2016
30. Study of specific IgE and IgG4 antibodies to mite antigen in asthmatic children during immunotherapy
- Author
-
Motoi Adachi, Toshihide Obe, Yasuo Chinzei, Hisashi Matsubara, Katsuhiko Ando, Yutaka Atsuta, Hiroyuki Matsuoka, and Yukari Matsushita
- Subjects
lcsh:Immunologic diseases. Allergy ,medicine.medical_treatment ,Immunoglobulin E ,Antigen ,lgG4 ,medicine ,Mite ,Dermatophagoides ,Immunology and Allergy ,Asthma ,biology ,business.industry ,General Medicine ,Immunotherapy ,medicine.disease ,biology.organism_classification ,Asthmatic children ,densitometer ,Immunology ,biology.protein ,Mite antigen ,bronchial asthma ,IgE ,immunotherapy ,Antibody ,business ,lcsh:RC581-607 ,immunoblotting - Abstract
Using immunoblotting and densitometer techniques, we followed the levels of IgE and IgG4 antibodies to Dermatophagoides farinae antigen in the sera of 12 asthmatic children during immunotherapy, repeated injections of house dust extract, for 2 years. The symptoms of asthma were reduced or disappeared by the 6th month after starting immunotherapy in 12 children. Two years later, RAST scores to house dust and D. farinae in each child were still 4 or 5. The levels of IgE antibodies to Der fII in all cases did not change drastically. IgE antibodies to higher molecular weight antigens (Der fI, fIII, fIV etc.) developed in some cases, suggesting that repeated injections of crude extract tended to induce IgE antibodies to alternative molecules in patients. The IgG4 antibody to Der fII increased in 10 cases, while that to Der fI increased in three of 12 cases, indicating that production of IgG4 antibodies to mite antigens started and expanded with repeated injections of house dust extract. The amount of induced IgG4 antibodies to Der fI and Der fII was not enough to inhibit the immunoblot reaction of IgE antibodies to these molecules.
- Published
- 1998
31. Incidence of retinal detachment associated with atopic dermatitis in Japan: review of cases from 1992 to 2011.
- Author
-
Mikio Sasoh, Hitoshi Mizutani, Hisashi Matsubara, Motoyasu Furuta, Yoshitsugu Matsui, Kei-ichi Yamanaka, and Mineo Kondo
- Subjects
RETINAL detachment ,ATOPIC dermatitis ,RETINAL diseases ,OPHTHALMIC surgery ,SKIN inflammation ,PREVENTION - Abstract
Purpose: The present study aims to investigate the number and characteristics of retinal detachment with atopic dermatitis (AD) in these 20 years, and the number of the first visit AD outpatients in almost the same period. Methods: A retrospective review of 101 consecutive surgically treated retinal detachments with AD patients from 1992 to 2011 was conducted. Retinal detachments were divided into two groups: eyes operated on from 1992 to 2001 (former AD group, n=63) and eyes operated on from 2002 to 2011 (recent AD group, n=38). We also reviewed the records of the first visit AD outpatients from 1993 to 2011 except 1998. Results: The percentage of bilateral detachment was significantly higher in the former AD group (14/63) than that in the recent AD group (0/38) (P=0.0002). In addition, patients in the recent AD group were significantly older than those in the former AD group (P=0.0084). The annual cases with non-AD retinal detachment remained invariant for 20 years. The ratio of the retinal detachment with AD for the total retinal detachment was significantly lower in the recent (38/847) AD group than that in the former (63/796) AD group (P=0.0038). The number of the first visit AD outpatients linearly decreased in these 19 years (153 cases in 1993 and 65 cases in 2011). Conclusion: Our study indicates an apparent decrease in retinal detachment with AD in the recent 10 years, and might suggest the importance of dermatitis control for prevention of retinal detachment with AD. [ABSTRACT FROM AUTHOR]
- Published
- 2015
- Full Text
- View/download PDF
32. Inducible nitric oxide synthase mediates retinal DNA damage in Goto-Kakizaki rat retina.
- Author
-
Izumi Yuasa, Ning Ma, Hisashi Matsubara, Yoshihiro Fukui, and Yukitaka Uji
- Subjects
THERAPEUTIC use of enzymes ,RETINAL (Visual pigment) ,DNA damage ,LABORATORY rats ,HYDROXY acids ,DIABETES ,IMMUNOHISTOCHEMISTRY ,NEUROTOXICOLOGY - Abstract
Abstract Purpose To examine the nitrosative and oxidative DNA damage induced by 8-nitroguanine and 8-hydroxy-2-deoxy guanosine (8-OHdG), and to determine the role played by inducible nitric oxide synthase (iNOS) in damage to DNA in the retina of the Goto-Kakizaki (GK) rat. Methods Experiments were performed on GK rats, an animal model of spontaneous type 2 diabetes without obesity or visible diabetic vascular lesions. Immunohistochemistry was used to determine the retinal distribution of 8-nitroguanine, 8-OHdG, and iNOS in GK rats and control rats. The change in the expression of 8-nitroguanine and 8-OHdG in GK rats was also determined following an intravitreal injection of 1400W, an inhibitor of iNOS activity. Results Immunohistochemical analysis showed that 8-nitroguanine and 8-OHdG were expressed strongly in the inner nuclear layer of GK retinas but only weakly in control retinas. This expression was correlated with an increase in the expression of iNOS in GK retinas, which was confirmed by the inhibition of iNOS activity by 1400W. Conclusion These findings demonstrate that iNOS plays a crucial role in nitrosative and oxidative DNA damage in GK rats, suggesting a retinal neurotoxic role of nitric oxide and superoxide in diabetic retinas. [ABSTRACT FROM AUTHOR]
- Published
- 2008
- Full Text
- View/download PDF
33. Exposure of haptic of posterior chamber intraocular lens after sutureless intrascleral fixation.
- Author
-
Yoshitsugu Matsui, Hisashi Matsubara, Tsukasa Hanemoto, and Mineo Kondo
- Subjects
INTRAOCULAR lenses ,SUTURING ,TISSUE fixation (Histology) ,SCLERA ,VISUAL acuity - Abstract
Background: A technique of sutureless intrascleral fixation of an intraocular lens (IOL) in an eye that lacks a posterior capsular support has been reported. The advantage of this technique was that the suture-related complications did not develop. However, the long-term complications of a sutureless IOL implantation have not been reported. Case presentation: A 75-years-old man had a sutureless intrascleral fixation (Y-fixation) of an IOL 4 months before our examination. The nasal haptic became exposed and the temporal haptic was seen in the subconjunctiva. The tilted IOL was removed and replaced by a posterior chamber IOL that was sutured to the sclera. At the 6 months examination, the eye was quiet and the IOL was stable. Conclusion: We suggest that the exposure of the nasal haptic of an IOL that was implanted by sutureless intrascleral fixation (Y-fixation) was due to poor surgical technique and/or the erosion of a fragile sclera. Thus, eyes should be carefully and frequently monitored after sutureless intrascleral posterior chamber IOL implantation. [ABSTRACT FROM AUTHOR]
- Published
- 2015
- Full Text
- View/download PDF
34. Exposure of haptic of posterior chamber intraocular lens after sutureless intrascleral fixation
- Author
-
Hisashi Matsubara, Mineo Kondo, Tsukasa Hanemoto, and Yoshitsugu Matsui
- Subjects
Male ,Reoperation ,medicine.medical_specialty ,Visual acuity ,genetic structures ,medicine.medical_treatment ,Visual Acuity ,Intraocular lens ,Case Report ,Fixation (surgical) ,Lens Implantation, Intraocular ,Ophthalmology ,medicine ,Humans ,Haptic technology ,Aged ,Lenses, Intraocular ,business.industry ,Suture Techniques ,General Medicine ,equipment and supplies ,eye diseases ,Surgery ,Sclera ,Prosthesis Failure ,Posterior chamber intraocular lens ,medicine.anatomical_structure ,sense organs ,medicine.symptom ,business - Abstract
Background A technique of sutureless intrascleral fixation of an intraocular lens (IOL) in an eye that lacks a posterior capsular support has been reported. The advantage of this technique was that the suture-related complications did not develop. However, the long-term complications of a sutureless IOL implantation have not been reported. Case presentation A 75-years-old man had a sutureless intrascleral fixation (Y-fixation) of an IOL 4 months before our examination. The nasal haptic became exposed and the temporal haptic was seen in the subconjunctiva. The tilted IOL was removed and replaced by a posterior chamber IOL that was sutured to the sclera. At the 6 months examination, the eye was quiet and the IOL was stable. Conclusion We suggest that the exposure of the nasal haptic of an IOL that was implanted by sutureless intrascleral fixation (Y-fixation) was due to poor surgical technique and/or the erosion of a fragile sclera. Thus, eyes should be carefully and frequently monitored after sutureless intrascleral posterior chamber IOL implantation.
- Full Text
- View/download PDF
35. Ocular hypertelorism and exotropia as presenting signs in Diamond-Blackfan anemia.
- Author
-
Hisashi Matsubara and Yukitaka Uji
- Published
- 2009
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.